Dr Aiste McCormick Professor Richard Edmondson
| DNA damage repair in ovarian cancer: Unlocking the heterogeneity | 2018 |
|
Dr Aiste McCormick Gavin Cuthbert Dr Rachel O'Donnell Dr Brian Wilson Huw Thomas et al. | Functional characterisation of a novel ovarian cancer cell line, NUOC-1 | 2017 |
|
Professor Richard Edmondson Dr Angelika Kaufmann
| Markers of the p53 pathway further refine molecular profiling in high-risk endometrial cancer: A TransPORTEC initiative | 2017 |
|
Dr Rachel O'Donnell Dr Angelika Kaufmann Dr Laura Woodhouse Dr Aiste McCormick Professor Richard Edmondson et al. | Advanced Ovarian Cancer Displays Functional Intratumor Heterogeneity That Correlates to Ex Vivo Drug Sensitivity | 2016 |
|
Barry Dent Laura Ogle Dr Rachel O'Donnell Dr Ujjal Mallick Professor Nicola Curtin et al. | High-resolution imaging for the detection and characterisation of circulating tumour cells from patients with oesophageal, hepatocellular, thyroid and ovarian cancers | 2016 |
|
Dr Rachel O'Donnell Professor Richard Edmondson
| Hormone replacement therapy after treatment for a gynaecological malignancy | 2016 |
|
Dr Laura Woodhouse Professor Richard Edmondson
| Ovarian Cancer | 2016 |
|
Maryam Zanjirband Zanjirband Professor Richard Edmondson Professor John Lunec
| Pre-clinical efficacy and synergistic potential of the MDM2-p53 antagonists, Nutlin-3 and RG7388, as single agents in combined treatment with cisplatin in ovarian cancer | 2016 |
|
Dr Aiste McCormick Professor Richard Edmondson
| A functional assay to determine the nucleotide excision repair status of ovarian cancer patients | 2015 |
|
Dr Amir Enshaei Professor Craig Robson Professor Richard Edmondson
| Artificial Intelligence Systems as Prognostic and Predictive Tools in Ovarian Cancer | 2015 |
|
Dr Aiste McCormick Dr Sirintra Nakjang Dr Peter Donoghue Professor Nicola Curtin Professor Richard Edmondson et al. | The role of homologous recombination recovery in cisplatin and rucaparib resistance in ovarian cancer | 2015 |
|
Dr Angelika Kaufmann Professor Richard Edmondson
| The use of a p53 signature identifies a group of high risk endometrial cancer associated with an excellent prognosis | 2015 |
|
Barry Dent Dr Rachel O'Donnell Laura Ogle Padmini Ramesh Nick Hayes et al. | Detection and characterization of circulating tumor cells by imaging flow cytometry | 2014 |
|
Dr Rachel O'Donnell Professor Richard Edmondson
| Gastric-type adenocarcinoma of the cervix in a patient with Lynch syndrome: A case report | 2014 |
|
Professor Richard Edmondson Dr Asima Mukhopadhyay Professor Nicola Curtin
| Molecular characterization of matched ovarian ascites and tumors suggests multiple mechanisms for a homologous recombination defective phenotype | 2014 |
|
Dr Rachel O'Donnell Dr Aiste McCormick Dr Asima Mukhopadhyay Michelle Dixon Dr Angelika Kaufmann et al. | The Use of Ovarian Cancer Cells from Patients Undergoing Surgery to Generate Primary Cultures Capable of Undergoing Functional Analysis | 2014 |
|
Dr Angelika Kaufmann Professor Richard Edmondson
| Use of Molecular Markers Improves Prognostic Stratification in High Risk Endometrial Cancer: A Transportec Collaborative Study | 2014 |
|
Dr Rachel O'Donnell Laura Woodhouse Dr Aiste McCormick Dr Asima Mukhopadhyay Michelle Dixon et al. | Functional Intra-Tumour Heterogeneity in Ovarian Cancer: What is a Representative Tumour Sample? | 2013 |
|
Dr Aiste McCormick Professor Richard Edmondson
| Inhibiting Double Strand Break (DSB) Repair Pathways and PTEN Sensitises Ovarian Clear Cell Carcinoma (OCCC) to Cytotoxic Agents | 2013 |
|
Dr Aiste McCormick Professor Nicola Curtin Professor Richard Edmondson
| Inhibition of DNA-PK Recovers HR Function and Results in Platinum Resistance in an Ovarian Cancer Cell Line Model | 2013 |
|
Dr Rachel O'Donnell Barry Dent Laura Ogle Professor Nicola Curtin Dr David Jamieson et al. | The Characterisation and Functional Assessment of Epithelial Ovarian Cancer Cells Derived from Ascitic Fluid using Imagestream | 2013 |
|